
Scalable iPSC Neuronal Assays for ASO Efficacy and Neurotoxicity

Scalable hiPSC Platform for ASO Efficacy and Toxicity Screening

Research highlights: Targeted Protein Degradation in Tauopathies

Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease

ALS Pathology and Drug Targets Using In Vitro iPSC Models
